EyePoint Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Jun2010 Jun2011 Jun2012 Jun2013 Jun2014 Jun2015 Jun2016 Jun2017 Jun2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 8.62M-8.63M-24.84M-11.90M-13.36M8.02M-21.55M-18.48M-53.17M
Depreciation and Depletion 0.04M0.05M0.19M0.23M0.14M0.11M0.15M0.09M0.17M0.14M0.19M0.31M0.40M0.50M1.54M
Share-based Compensation 1.50M2.05M1.41M1.32M1.41M1.96M2.16M2.46M2.70M4.57M5.55M7.45M14.18M12.06M36.74M
Deferred Taxes -0.21M-0.01M0.08M0.09M
Gains from Sales and Divestitures 0.11M
Gains from Investment Securities 0.08M2.61M3.05M3.55M0.84M0.26M4.98M6.05M6.46M0.12M0.09M0.15M0.29M0.17M17.54M
Asset Writedowns and Impairment 14.83M1.28M20.70M0.69M
Non-cash Items 0.00M2.40M5.12M2.89M1.01M0.13M0.70M
Cash from Operations 9.90M-3.17M-9.00M-8.74M-10.67M10.30M-16.32M-20.49M-21.91M-56.70M-14.44M-50.10M-65.00M1.88M-126.23M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 3.29M3.30M2.04M0.77M0.78M0.77M0.76M0.72M0.98M2.50M2.50M2.50M2.05M
Amortization of Deferred Charges 0.21M1.05M0.98M0.63M
Depreciation & Amortization (CF) 0.04M0.05M0.19M0.23M0.14M0.11M0.15M0.09M0.17M0.14M0.19M0.31M0.40M0.50M1.54M
Change in Working Capital
Change in Receivables 0.29M-0.28M0.13M-0.36M-0.10M0.12M-0.12M-0.12M0.17M15.30M-4.85M10.60M2.66M-14.43M0.24M
Change in Inventory 1.86M3.20M-1.35M0.76M1.55M-1.60M
Change in Account Payables 0.11M-0.06M0.06M0.28M-0.21M0.29M0.63M-0.35M1.75M
Change in Accured Expenses -0.36M0.15M-0.71M1.29M-0.38M1.05M1.04M0.30M1.16M4.60M1.87M8.48M1.20M1.52M5.73M
Other Working Capital Changes -3.53M0.88M-1.90M1.27M-1.11M0.14M-0.19M-0.10M-0.05M-0.01M16.55M-0.93M-0.87M44.52M-30.65M
Investing Activities
Capital Expenditures 0.01M0.13M0.41M0.07M0.25M0.16M0.11M0.15M0.11M0.21M0.36M0.16M2.15M3.48M4.05M
Sales of Property, Plant and Equipment 0.08M0.03M
Acquisitions 16.78M
Change in Acquisitions & Divestments 6.60M1.10M14.18M3.65M13.17M18.74M124.00M55.28M183.00M
Cash from Investing Activities -2.07M-9.50M0.61M6.36M0.07M-6.73M-4.46M13.58M-16.89M-0.21M-0.36M-33.12M-17.27M-3.31M-219.35M
Financing Activities
Other financing activities 1.35M1.34M-0.09M-0.15M-0.29M0.45M-4.51M
Cash from Financing Activities 0.80M10.06M0.11M4.67M19.04M0.23M16.99M8.50M60.67M33.86M37.49M216.90M-0.69M187.07M164.02M
Additional items
Exchange Rate Effect -0.02M0.01M-0.01M-0.01M-0.00M-0.01M-0.02M-0.01M0.00M0.00M
Change in Cash 8.62M-2.60M-8.29M2.27M8.44M3.79M-3.81M1.58M21.88M-23.05M22.70M133.68M-82.96M185.63M-181.56M
Free Cash Flow 9.88M-3.30M-9.41M-8.81M-10.92M10.14M-16.43M-20.64M-22.02M-56.91M-14.80M-50.25M-67.16M-1.61M-130.28M
Net Cash Flow 8.63M-2.61M-8.28M2.28M8.44M3.80M-3.79M1.59M21.88M-23.05M22.70M133.68M-82.96M185.63M-181.56M